IP Library Patent Application 15968358
Patent Application
App. No. 15/968,358

THERAPEUTIC REGIMEN AND METHODS FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/968,358
Abstract

Disclosed herein are therapeutic regimens for treating or ameliorating a visual disorder associate with an endogenous retinoid deficiency in a subject by administering a therapeutically effective amount of a synthetic retinal derivative or a pharmaceutically acceptable composition comprising a synthetic retinal derivative according to the therapeutic regimen which leads to local recovery of visual functions such as visual fields, visual acuity and retinal sensitivity, among others.

Claims (9)

1 . A method for treating a patient suffering from the loss or impairment of vision caused by a retinoid deficiency disorder, comprising the steps of:

a) administering to the patient an initial therapeutically effective dose of a synthetic retinal derivative that provides replacement for endogenously produced 11-cis-retinal,

b) refraining from administering to the patient an additional therapeutically effective dose of synthetic retinal derivative for a resting interval of at least 1 month,

c) administering to the patient an additional therapeutically effective dose of a synthetic retinal derivative.

2 - 33 . (canceled)

34 . A kit for use in the treatment or amelioration of a visual disorder associated with an endogenous retinoid deficiency in a subject, the kit comprising:

(i) a therapeutic effective amount of a synthetic retinal derivative, or a therapeutic effective amount of a pharmaceutically acceptable composition comprising a synthetic retinal derivative; and

(ii) instructions for administering the synthetic retinal derivative or the pharmaceutically acceptable composition to the subject

35 . A method of preparing a medicament for administration to a subject having an endogenous retinoid deficiency, the method comprising formulating a synthetic retinal derivative with a pharmaceutically acceptable vehicle.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: RETINAGENIX THERAPEUTICS, INC.
To: RETINAGENIX HOLDINGS LLC
Reel/Frame 055857/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2020
From: RETINAGENIX, LLC
To: RETINAGENIX THERAPEUTICS, INC.
Reel/Frame 052175/0176 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2019
From: NOVELION THERAPEUTICS INC.
To: RETINAGENIX, LLC
Reel/Frame 048403/0004 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2019
From: STRONG, H. ANDREW; CADDEN, SUZANNE
To: QLT INC.
Reel/Frame 048383/0396 →
CHANGE OF NAME Recorded Feb 20, 2019
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 048383/0577 →